hero-line-left hero-line-top

Insights from a global oncology network

Syapse Oncology enables healthcare providers to deliver consistent, cost-effective, patient-centered cancer care.


The complexity of precision medicine requires insights from the real world

Syapse offerings for health systems enable:

icon circle checkmark High-level oversight of the practice of precision medicine at your health system
icon circle checkmark Optimization of your clinical trial portfolio for your real-world oncology patient population
icon circle checkmark The application of molecular diagnostics data to clinical care decisions
  • Syapse Executive

    Actionable insights to understand and improve the success of your precision medicine program.

  • Syapse Insights

    Use integrated clinical and molecular data to increase access to clinical trials and publish studies.

  • Syapse Oncology

    Use clinical and molecular data to support decision making and streamline workflows.

Connectivity with clinical databases, systems, and sources

Precision medicine requires centralized access to patient data that are typically siloed in electronic health records (EHRs), data warehouses, registries, and other systems. Syapse integrates patients’ clinical, pathology, radiology, treatment, lab results, and other information in a central data store to provide a single point of access.

Direct integration with molecular labs to capture structured molecular data

Today, genomic and other molecular test results are typically scanned into EHR systems and stored as unstructured data. Through direct integration with molecular diagnostics labs, Syapse enables healthcare systems to capture molecular profiles as structured data that can be used for decision support in the clinical workflow.

Common data standards across the network

Syapse standardizes and normalizes a robust set of data from multiple systems, allowing health systems to share data with other institutions, including patient demographics, cancer diagnoses, tumor genomics, tumor markers, treatments, and outcomes.


  • Syapse Overview Brochure
  • Syapse Offerings for Health Systems
  • Standing Up Precision Medicine: 7 Informed Practices for Leading Health Systems
  • Implementing an Oncology Precision Medicine Clinic in a Large Community Health System,” by Thompson, et al. in AJMC
  • Building a Personalized Medicine Program,” by Thomas D. Brown of the Swedish Cancer Institute
  • Role of Community-Based Genomics Programs,” by Thomas D. Brown of the Swedish Cancer Institute

In the news

Biden Cancer Initiative pairs up with IBM, Syapse to improve access to clinical trial information

6/4/19 - The Biden Cancer Initiative has announced that multiple healthcare organizations — including BreastCancerTrials.org, IBM Watson Health, Massive Bio and Syapse — are creating a shared platform called the Oncology Clinical Trial Information Commons, which will help cancer patients to know their clinical trial options.



Precision Medicine Goes Mainstream at Leading Health Systems

Precision medicine (or personalized medicine) has been a buzzword in the healthcare industry for many years. Depending on the audience, its…